| Literature DB >> 29780318 |
Cay Anderson-Hanley1, Nicole M Barcelos1, Earl A Zimmerman2, Robert W Gillen3, Mina Dunnam4, Brian D Cohen5, Vadim Yerokhin6, Kenneth E Miller7, David J Hayes1, Paul J Arciero8, Molly Maloney1, Arthur F Kramer9.
Abstract
Prior research has found that cognitive benefits of physical exercise and brain health in older adults may be enhanced when mental exercise is interactive simultaneously, as in exergaming. It is unclear whether the cognitive benefit can be maximized by increasing the degree of mental challenge during exercise. This randomized clinical trial (RCT), the Aerobic and Cognitive Exercise Study (ACES) sought to replicate and extend prior findings of added cognitive benefit from exergaming to those with or at risk for mild cognitive impairment (MCI). ACES compares the effects of 6 months of an exer-tour (virtual reality bike rides) with the effects of a more effortful exer-score (pedaling through a videogame to score points). Fourteen community-dwelling older adults meeting screening criteria for MCI (sMCI) were adherent to their assigned exercise for 6 months. The primary outcome was executive function, while secondary outcomes included memory and everyday cognitive function. Exer-tour and exer-score yielded significant moderate effects on executive function (Stroop A/C; d's = 0.51 and 0.47); there was no significant interaction effect. However, after 3 months the exer-tour revealed a significant and moderate effect, while exer-score showed little impact, as did a game-only condition. Both exer-tour and exer-score conditions also resulted in significant improvements in verbal memory. Effects appear to generalize to self-reported everyday cognitive function. Pilot data, including salivary biomarkers and structural MRI, were gathered at baseline and 6 months; exercise dose was associated with increased BDNF as well as increased gray matter volume in the PFC and ACC. Improvement in memory was associated with an increase in the DLPFC. Improved executive function was associated with increased expression of exosomal miRNA-9. Interactive physical and cognitive exercise (both high and low mental challenge) yielded similarly significant cognitive benefit for adherent sMCI exercisers over 6 months. A larger RCT is needed to confirm these findings. Further innovation and clinical trial data are needed to develop accessible, yet engaging and effective interventions to combat cognitive decline for the growing MCI population. ClinicalTrials.gov ID: NCT02237560.Entities:
Keywords: Alzheimer's disease; MCI; aging; cognitive; dementia; exercise; exergame; neuropsychological
Year: 2018 PMID: 29780318 PMCID: PMC5945889 DOI: 10.3389/fnagi.2018.00076
Source DB: PubMed Journal: Front Aging Neurosci ISSN: 1663-4365 Impact factor: 5.750
Figure 1Stationary bike equipped with virtual reality display (aka “cybercycle” so named in our previous RCT; Anderson-Hanley et al., 2012). Former study participant demonstrating use of a cybercycle exergame; used with permission.
Figure 2Exer-tour (relatively cognitively passive) vs. Exer-score (cognitively effortful). Exer-tour (pedaling controls speed on screen and progress along scenic bike paths; involves steering, but relatively passive compared to exer-score; for example, can't leave road or crash into anything or any rider which one can steer through; could cease steering without consequence other than tilted view, bike will follow curb). Exer-score (requires navigating in 360° radius to locate colored coins and matching colored dragons of varying speed/difficulty to steer through; the goal is to score points and strategy may be employed to avoid losing points by avoiding hazards, while also seeking out bonus points available via tagging specialized objects one can choose to explore). Former study participant demonstrating exer-tour condition; used with permission.
Figure 3CONSORT flow diagram showing participant enrollment, randomization, and status in trial and analysis.
Exer-tour vs. exer-score baseline demographics for adherent completers (0–6M).
| Age | 80.9 | 12.3 | 7 | 75.4 | 9.83 | 7 | 0.38 | 78.1 | 11.0 | 14 | 80.9 | 8.2 | 54 | 0.31 |
| Education (yrs) | 14.9 | 2.3 | 7 | 16.6 | 2.76 | 7 | 0.23 | 15.7 | 2.6 | 14 | 16.1 | 2.5 | 52 | 0.61 |
| Sex (% female) | 57% | 43% | 0.63 | 50% | 69% | 0.20 | ||||||||
| Est IQ (NAART) | 128.5 | 11.9 | 7 | 136.8 | 5.26 | 7 | 0.12 | 132.7 | 9.8 | 14 | 134.3 | 7.3 | 54 | 0.49 |
| Cog fn (MoCA) | 21.6 | 2.7 | 7 | 22.0 | 3.21 | 7 | 0.79 | 21.8 | 2.9 | 14 | 22.6 | 2.0 | 54 | 0.20 |
| Retired | 100% | 7 | 100% | 7 | ns | 100% | 86% | 0.15 | ||||||
| BMI | 24.8 | 3.9 | 7 | 26.3 | 2.73 | 7 | 0.43 | 25.6 | 3.3 | 14 | 26.9 | 3.7 | 54 | 0.24 |
| Cog activities (CAS) | 17.9 | 4.5 | 7 | 20.1 | 3.98 | 7 | 0.34 | 19.0 | 4.3 | 14 | 19.3 | 8.3 | 54 | 0.89 |
| Experience bike | 2.4 | 0.79 | 7 | 2.3 | 0.76 | 7 | 0.74 | 2.4 | 0.74 | 14 | 2.1 | 0.84 | 52 | 0.39 |
| Experience computers | 2.1 | 1.1 | 7 | 3.1 | 1.07 | 7 | 0.11 | 2.6 | 1.2 | 14 | 2.6 | 1.2 | 52 | 0.98 |
| Experience videogames | 0.43 | 0.79 | 7 | 1.3 | 0.76 | 7 | 0.06 | 0.9 | 0.86 | 14 | 0.69 | 0.85 | 52 | 0.52 |
| Motivated | 2.6 | 0.53 | 7 | 2.4 | 0.53 | 7 | 0.63 | 2.5 | 0.52 | 14 | 2.7 | 0.47 | 51 | 0.20 |
| PAR | 0.86 | 0.69 | 7 | 0.86 | 0.69 | 7 | 1.00 | 0.9 | 0.66 | 14 | 1.1 | 1.0 | 50 | 0.31 |
| Physical activity level (SRPA) | 2.9 | 1.3 | 7 | 3.6 | 0.98 | 7 | 0.28 | 3.2 | 1.2 | 14 | 2.9 | 1.2 | 47 | 0.43 |
| Functional disability (FAQ) | 8.1 | 9.0 | 7 | 1.6 | 1.81 | 7 | 0.08 | 4.9 | 7.1 | 14 | 2.8 | 4.7 | 49 | 0.06 |
| Average num rides/wk | 3.9 | 1.2 | 7 | 4.0 | 1.1 | 7 | 0.86 | |||||||
| HR average | 102.9 | 13.6 | 7 | 108.2 | 22.1 | 7 | 0.60 | |||||||
| Mental effort (self-report) | 1.8 | 0.75 | 6 | 3.1 | 0.69 | 7 | ||||||||
Comparison between groups.
b Comparison with baseline.
c Repeated meas ANCOVA controlling for age and education.
Bold value indicate statistically significant (p ≤ 0.05).
Figure 4Exer-tour vs. exer-score for sMCI adherents 0–6M.
Exer-tour vs. exer-score for primary neuropsychological outcomes (0–3M−6M).
| Color Trails | 0.49 | 0.17 | 7 | 0.47 | 0.10 | 7 | 0.85 | 0.48 | 0.13 | 14 | 0.48 | 0.21 | 54 | |||
| Stroop A/C | 0.40 | 0.12 | 7 | 0.40 | 0.14 | 7 | 0.98 | 0.40 | 0.12 | 14 | 0.44 | 0.12 | 54 | |||
| Digits B/F | 0.53 | 0.13 | 7 | 0.59 | 0.21 | 7 | 0.56 | 0.56 | 0.17 | 14 | 0.61 | 0.16 | 54 | |||
| Color Trails | 0.44 | 0.11 | 7 | 0.41 | 0.44 | 0.07 | 7 | 0.34 | 0.44 | 0.09 | 14 | 0.20 | 0.89 | |||
| Stroop A/C | 0.45 | 0.06 | 7 | 0.25 | 0.41 | 0.15 | 7 | 0.68 | 0.43 | 0.11 | 14 | 0.21 | 0.46 | |||
| Digits B/F | 0.53 | 0.23 | 7 | 0.97 | 0.61 | 0.12 | 7 | 0.65 | 0.57 | 0.18 | 14 | 0.77 | 0.93 | |||
| Color Trails 1/2 | 0.38 | 0.12 | 6 | 0.10 | 0.48 | 0.17 | 7 | 0.83 | 0.44 | 0.15 | 13 | 0.32 | 0.11 | |||
| Stroop A/C | 0.48 | 0.11 | 6 | 0.47 | 0.15 | 7 | 0.47 | 0.13 | 13 | 0.82 | ||||||
| Digits B/F | 0.60 | 0.15 | 6 | .38 | 0.64 | 0.16 | 7 | 0.50 | 0.62 | 0.15 | 13 | 0.26 | 0.99 | |||
Comparison between groups.
Comparison with baseline.
Repeated meas ANCOVA controlling for age and education.
Bold values indicates statistically significant (p ≤ 0.05).
Figure 5Comparison of effect sizes of components of interactive physical and cognitive exercise across four intervention conditions for 0–3M adherents. p-values represent significant change over time within-group (paired) t-tests. athe game-only condition was initially randomly assigned, but subsequently recruited separately due to challenges with enrollment and retention (see section Methods for further details). bthe pedal-only comparison data is archival/perviously reported from our lab and was obtained during the Cybercycle Study (Anderson-Hanley et al., 2012), which examined only a 3-month interval and was collected from older adults in the same region, from many of the same retirement communities, and with the same measures of executive function; this data is included here as a point of comparaitve reference, illustrating the magnitude of effect from physical exercise alone.
Exer-tour vs. exer-score for secondary outcomes: memory, everyday function (self-reported cognition and physical ability (0–6M).
| Verbal Mem Immed (errors) | 15.71 | 4.39 | 7 | 14.43 | 5.50 | 7 | 0.64 | 15.1 | 4.8 | 14 | 11.96 | 3.62 | 54 | |||
| Verbal Mem Delay (errors) | 6.0 | 2.8 | 7 | 6.6 | 2.8 | 7 | 0.71 | 6.3 | 2.7 | 14 | 5.2 | 2.3 | 54 | |||
| Ecological Validity | 35.5 | 7.9 | 7 | 40.2 | 9.8 | 7 | 0.34 | 37.8 | 8.9 | 14 | 41.6 | 7.9 | 50 | |||
| Physical ability (GUG) | 12.7 | 2.2 | 7 | 10.3 | 1.7 | 7 | 11.5 | 2.3 | 14 | 12.7 | 3.5 | 54 | ||||
| Verbal Mem Immed (errors) | 11.17 | 4.49 | 6 | 12.71 | 4.31 | 7 | 0.10 | 12.0 | 4.3 | 13 | ||||||
| Verbal Mem Delay (errors) | 5.5 | 3.0 | 6 | 0.53 | 5.1 | 2.9 | 7 | 5.3 | 2.8 | 13 | 0.15 | |||||
| Ecological Validity | 41.3 | 7.3 | 6 | 0.20 | 36.6 | 7.2 | 7 | 0.12 | 38.8 | 7.3 | 13 | 0.84 | ||||
| Physical ability (GUG) | 14.0 | 1.5 | 6 | 11.0 | 2.0 | 6 | 0.46 | 12.5 | 2.3 | 12 | ||||||
Comparison between groups.
Comparison with baseline.
Repeated meas ANCOVA controlling for age and education.
Bold values indicates statistically significant (p ≤ 0.05).
Neurobiological change (0–6M) correlates with exercise dose/effort and change in cognitive function for participants in exer-tour and exer-score: Exploratory pilot data.
| BDNF | 0.50 | 0.20 | 0.21 | |
| 0.42 | 0.39 | |||
| 15 | 16 | 16 | ||
| CRP | 0.00 | 0.16 | −0.34 | |
| 0.99 | 0.53 | 0.16 | ||
| 15 | 16 | 16 | ||
| IL-6 | 0.03 | 0.15 | −0.06 | |
| 0.91 | 0.54 | 0.82 | ||
| 15 | 16 | 16 | ||
| VEGF | −0.30 | −0.05 | −0.42 | |
| 0.25 | 0.84 | 0.08 | ||
| 15 | 16 | 16 | ||
| Exosome (miR-9_N0_Rel_U6) | −0.394 | 0.984 | −0.815 | |
| 0.51 | 0.09 | |||
| 3 | 3 | 3 |
Controlling for age and sex.
Bold values indicates statistically significant (p ≤ 0.05).
Neuroimaging change (0–6M) correlations with exercise dose/effort and changes in cognitive function (0–6M) for participants in exer-tour and exer-score: Exploratory pilot data.
| Hippocampus (left) | 0.07 | 0.22 | 0.02 | |
| 0.86 | 0.55 | 0.95 | ||
| 6 | 8 | 8 | ||
| Hippocampus (right) | 0.14 | 0.14 | 0.08 | |
| 0.74 | 0.69 | 0.83 | ||
| 6 | 8 | 8 | ||
| DLPFC | −0.10 | 0.19 | −0.80 | |
| 0.84 | 0.62 | |||
| 5 | 7 | 7 | ||
| PFC | 0.89 | 0.51 | 0.07 | |
| 0.13 | 0.85 | |||
| 6 | 8 | 8 | ||
| ACC (left) | −0.42 | −0.36 | −0.43 | |
| 0.30 | 0.30 | 0.21 | ||
| 6 | 8 | 8 | ||
| ACC (right) | 0.70 | −0.14 | 0.00 | |
| 0.70 | 1.00 | |||
| 6 | 8 | 8 |
Controlling for age and sex.
Bold values indicates statistically significant (p ≤ 0.05).
Figure 6Neuroimaging correlates with exercise and cognition: MRI of ACC and DLPFC. Notes: Illustration of regions-of-interest (ROI): ACC (increased with exercise dose) and DLPFC (increased with improvement in verbal memory); shown here in one individual and in one hemisphere for ease of presentation. Images of ACC (green) and DLPFC (blue) in 3 sagittal (A), coronal (B), and axial (C) images aligned by crosshairs. ROI 3D model reconstructions give a sense of their structure in 3D space, as seen from the anterior (D) and left (E) sides.